Rosenblatt Upgrades CME Group (CME) to Neutral
Tweet Send to a Friend
Rosenblatt analyst Sean Horgan upgraded CME Group (NASDAQ: CME) from Sell ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
